Crossmark Global Holdings’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-3,703
Closed -$272K – 1351
2023
Q4
$272K Sell
3,703
-257
-6% -$17.4K 0.01% 1111
2023
Q3
$283K Sell
3,960
-379
-9% -$30.3K 0.01% 1043
2023
Q2
$378K Sell
4,339
-145
-3% -$12.7K 0.01% 959
2023
Q1
$400K Buy
4,484
+123
+3% +$10.7K 0.01% 916
2022
Q4
$374K Sell
4,361
-270
-6% -$22.9K 0.01% 926
2022
Q3
$331K Buy
4,631
+230
+5% +$20.6K 0.01% 942
2022
Q2
$428K Sell
4,401
-3,109
-41% -$317K 0.01% 873
2022
Q1
$845K Buy
7,510
+2,810
+60% +$299K 0.02% 689
2021
Q4
$634K Sell
4,700
-1,560
-25% -$217K 0.01% 798
2021
Q3
$884K Sell
6,260
-180
-3% -$24.2K 0.02% 650
2021
Q2
$825K Sell
6,440
-230
-3% -$27.1K 0.02% 675
2021
Q1
$853K Buy
6,670
+80
+1% +$14.8K 0.02% 652
2020
Q4
$1.18M Buy
6,590
+2,050
+45% +$456K 0.03% 527
2020
Q3
$996K Sell
4,540
-110
-2% -$24.5K 0.03% 550
2020
Q2
$1.04M Buy
+4,650
New +$729K 0.03% 528

Other funds holding QDEL

Crossmark Global Holdings's QDEL Position: Q1 2024 in Review

Crossmark Global Holdings sold out of QuidelOrtho (QDEL) in Q1 2024, closing a stake of 3,703 shares — an estimated $272K sold.

Crossmark Global Holdings first reported a position in QDEL in Q2 2020 and held it in 15 quarters. The position peaked at $1.18M in Q4 2020. 271 funds tracked by Wall St. Rank hold QDEL as of Q1 2024.

  • Crossmark Global Holdings reported no remaining QuidelOrtho position as of Q1 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 3,703 QuidelOrtho shares in Q1 2024, an estimated $272K.
  • Crossmark Global Holdings first reported a position in QuidelOrtho in Q2 2020 and held it in 15 quarters.
  • Crossmark Global Holdings's QuidelOrtho position peaked at $1.18M in Q4 2020.
  • 271 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2024.

Based on Crossmark Global Holdings's 13F filing for Q1 2024, filed 13 May 2024.